These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6791548)

  • 1. Human protein C: inactivation of factors V and VIII in plasma by the activated molecule.
    Marlar RA; Kleiss AJ; Griffin JH
    Ann N Y Acad Sci; 1981; 370():303-10. PubMed ID: 6791548
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of factor VIII by activated protein C and protein S.
    Walker FJ; Chavin SI; Fay PJ
    Arch Biochem Biophys; 1987 Jan; 252(1):322-8. PubMed ID: 2949697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor IXa protects activated factor VIII against inactivation by activated protein C.
    Bertina RM; Cupers R; van Wijngaarden A
    Biochem Biophys Res Commun; 1984 Nov; 125(1):177-83. PubMed ID: 6439201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation.
    Váradi K; Rosing J; Tans G; Pabinger I; Keil B; Schwarz HP
    Thromb Haemost; 1996 Aug; 76(2):208-14. PubMed ID: 8865533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles.
    Jalbert LR; Chan JC; Christiansen WT; Castellino FJ
    Biochemistry; 1996 Jun; 35(22):7093-9. PubMed ID: 8679535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.
    Marlar RA; Kleiss AJ; Griffin JH
    Blood; 1982 May; 59(5):1067-72. PubMed ID: 6803853
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protein C--a selective inhibitor of blood coagulation].
    Dmoszyńska-Giannopoulou A; Rupniewska ZM
    Pol Arch Med Wewn; 1984 May; 71(5):313-6. PubMed ID: 6435099
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein S and the regulation of activated protein C.
    Walker FJ
    Semin Thromb Hemost; 1984 Apr; 10(2):131-8. PubMed ID: 6234659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of VIII:C in plasma: the dependence on protease activity and calcium.
    Rock GA; Cruickshank WH; Tackaberry ES; Ganz PR; Palmer DS
    Thromb Res; 1983 Mar; 29(5):521-35. PubMed ID: 6407138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
    Koedam JA; Meijers JC; Sixma JJ; Bouma BN
    J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of human factor VIII by activated protein C: evidence that the factor VIII light chain contains the activated protein C binding site.
    Fay PJ; Walker FJ
    Biochim Biophys Acta; 1989 Feb; 994(2):142-8. PubMed ID: 2521291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.
    RATNOFF OD; MILES AA
    Br J Exp Pathol; 1964 Jun; 45(3):328-45. PubMed ID: 14173175
    [No Abstract]   [Full Text] [Related]  

  • 14. A new anticoagulant extracted from the red cell.
    Cochin A; Dubin A; DeWoskin R; Gilbert HC; Moss GS
    Surg Forum; 1973; 24():70-2. PubMed ID: 4806101
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased resistance of factor IXa-factor VIII complex against inactivation by granulocyte proteases.
    Váradi K; Elõdi S
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):571-8. PubMed ID: 6777896
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acquired coagulant factor inhibitors].
    Nogami K
    Rinsho Ketsueki; 2013 Oct; 54(10):1907-14. PubMed ID: 24064842
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.
    Walker FJ; Sexton PW; Esmon CT
    Biochim Biophys Acta; 1979 Dec; 571(2):333-42. PubMed ID: 508770
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].
    Abe T; Kazama M; Itokazu K; Kinoshita T; Ogushi T; Tahara C; Fukui H
    Rinsho Ketsueki; 1980 Nov; 21(11):1664-73. PubMed ID: 6782277
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va.
    Suzuki K; Nishioka J; Matsuda M; Murayama H; Hashimoto S
    J Biochem; 1984 Aug; 96(2):455-60. PubMed ID: 6238950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.